With $4.8 million from the NIH, Gladstone scientists will investigate how the protein apoE4 causes neurodegeneration in Alzheimer's disease.
A recent review suggests that a phospholipid form of omega-3 in fish and fish roe may reduce Alzheimer's disease risk in APOE4 carriers.
New insights into how a gene causes damage could impact future drug development
